Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-24
1994-03-01
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544225, 544226, 544273, C07D47302, A61K 3152
Patent
active
052907821
ABSTRACT:
Novel xanthine compounds represented by the following formula: ##STR1## wherein each of X.sup.1 and X.sup.2 independently represents oxygen or sulfur; and Q represents; ##STR2## where ----- represents a single bond or a double bond; Y represents a single bond or alkylene, n represents 0 or 1, each of W.sup.1 and W.sup.2 independently represents hydrogen, lower alkyl or amino, Z represents --CH.sub.2 -, --O--, --S-- or --NH--; represents ##STR3## each of R.sup.1 and R.sup.2 independently represents hydrogen, lower alkyl, allyl or propargyl; and R.sup.3 represents hydrogen or lower alkyl, and when Q represents the groups other than ##STR4## each of R.sup.1, R.sup.2 and R.sup.3 independently represents hydrogen or lower alkyl;
provided that when Q is ##STR5## then R.sup.1 R.sup.2 and R.sup.3 are not
simultaneously methyl; and pharmaceutically acceptable salts thereof have a diuretic effect, a renal-protecting effect and a bronchodilatory effect.
REFERENCES:
patent: 4548820 (1985-10-01), Regnier et al.
patent: 4603203 (1986-07-01), Furukawa et al.
patent: 4925847 (1990-05-01), Hofer
Chemical Abstracts, vol. 63, No. 13, Dec. 20, 1965 p. 18120, Column 2, Abstract No. 18120d.
The Merck Index, (1983), 10th ed. 9110.
Castagnino, et al, Tetrahedron Lett., (1986) 27, 6337.
Goodsell, et al., J. Med. Chem., (1971) vol. 14, 1202.
Kellett, et al., Br. J. Pharmacol., (1989), vol. 96, 31P.
Kellett, et al., Br. J. Pharmacol, (1989), vol. 97, 502P.
Coulson, et al., J. Pharmacol. Exp. Ther. (1989), vol. 248(2), 589.
Bruns, et al., "Adenosine and Adenine Nucleotides: Physiology and Pharmacology," (1988), p. 39 (D. M. Paton, Ed).
Martinson, et al., Mol. Pharmacol., (1987), vol. 31, 247.
Shamin et al., J. Med. Chem., (1989) vol. 32, 1231.
Jacobson, et al., Biochem. Pharmacol., (1988) vol. 37, 3653.
Shamim, et al., J. Med Chem., (1989), vol. 32, 1231.
Jacobson, et al., J. Med. Chem., (1989), vol. 32, 1873.
Katsushima, et al., J. Med. Chem., (1990), vol. 33, 1906.
Ishii Akio
Karasawa Akira
Kubo Kazuhiro
Nonaka Hiromi
Ohno Tetsuji
Cintins Marianne M.
Kyowa Hakko Kogyo Co. Ltd.
Scalzo Catherine
LandOfFree
Xanthine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577282